相似文献
1
[Which partner for the betalactam agent in empiric combined therapy? I Fluoroquinolone].
Ann Fr Anesth Reanim. 2004 Jun;23(6):636-8. doi: 10.1016/j.annfar.2004.05.012.
2
[Which partner for the betalactam agent in empirical combined therapy? II. Aminoglycoside].
Ann Fr Anesth Reanim. 2004 Jun;23(6):639-42. doi: 10.1016/j.annfar.2004.05.010.
3
Antibiotics in primary care: focus on fluoroquinolones and other new and investigational antimicrobial agents.
Lippincotts Prim Care Pract. 1999 Jan-Feb;3(1):39-54.
4
[Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
Rev Med Suisse. 2006 Jan 25;2(50):289-90, 292-4.
5
[New antibacterial agents].
Duodecim. 1999;115(20):2259-64.
6
Will fluoroquinolones ever be recommended for common infections in children?
Pediatr Infect Dis J. 2007 Oct;26(10):865-7. doi: 10.1097/INF.0b013e3180cc20e4.
7
Trovafloxacin: fourth generation fluoroquinolone.
Conn Med. 1998 Aug;62(8):483-7.
8
Fluoroquinolone resistance: mechanisms and epidemiology.
J Med Microbiol. 1997 Jun;46(6):457-61.
9
The newer fluoroquinolones.
Infect Dis Clin North Am. 2004 Sep;18(3):691-716, x. doi: 10.1016/j.idc.2004.04.011.
10
The newer fluoroquinolones.
Infect Dis Clin North Am. 2009 Dec;23(4):1027-51, x. doi: 10.1016/j.idc.2009.06.003.
Zotero 插件